Fall risk-increasing drugs and associated health outcomes among community-dwelling older patients: A cross-sectional study in Croatian cohort of the EuroAgeism H2020 project

1P. Zaninotto, Y. T. Huang, G. Di Gessa, J. Abell, C. Lassale and A. Steptoe, Polypharmacy is a risk factor for hospital admission due to a fall: Evidence from the English Longitudinal Study of Ageing, BMC Public Health 20 (2020) Article ID 1804 (7 pages); https://doi.org/10.1186/s12889-020-09920-xSearch in Google Scholar

2A. Cherubini, M. L. Laroche and M. Petrovic, Mastering the complexity: drug therapy optimization in geriatric patients, Eur. Geriatr. Med. 12 (2021) 431–434; https://doi.org/10.1007/s41999-021-00493-5Search in Google Scholar

3D. Frankenthal, M. Saban, D. Karolinsky, M. Lutski, S. Sternberg, I. Rasooly, I. Laxer and I. Zucker, Falls and fear of falling among Israeli community-dwelling older people: a cross-sectional national survey, Isr. J. Health Policy Res. 10 (2021) Article ID 29 (8 pages); https://doi.org/10.1186/s13584-021-00464-ySearch in Google Scholar

4D. J. Bolding, E. Corman, Falls in the geriatric patient, Clin. Geriatr. Med. 35 (2019) 115–126; https://doi.org/10.1016/j.cger.2018.08.010Search in Google Scholar

5A. L. Shaver, C. M. Clark, M. Hejna, S. Feuerstein, R. G. Wahler Jr. and D. M. Jacobs, Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States, 1999–2017, Pharmacoepidemiol. Drug Saf. 30 (2021) 1049–1056; https://doi.org/10.1002/pds.5201Search in Google Scholar

6S. Porta, A. Martínez, N. Millor, M. Gómez and M. Izquierdo, Relevance of sex, age and gait kinematics when predicting fall-risk and mortality in older adults, J. Biomech. 105 (2020) Article ID 109723; https://doi.org/10.1016/j.jbiomech.2020.109723Search in Google Scholar

7Centers for Disease Control and Prevention National Center for Injury Prevention and Control WISQARS (Web-based Injury Statistics Query and Reporting System); https://wisqars.cdc.gov/; last access date October 28, 2023.Search in Google Scholar

8WHO, Falls; https://www.who.int/news-room/fact-sheets/detail/falls; last access date October 28, 2023.Search in Google Scholar

9EuroSafe, Injuries in the European Union, Summary on injury statistics 2012–2014, 6th ed., Amsterdam 2016.Search in Google Scholar

10A. Correa-Pérez, E. Delgado-Silveira, S. Martín-Aragón and A. J. Cruz-Jentoft, Fall-risk increasing drugs and recurrent injurious falls association in older patients after hip fracture: a cohort study protocol, Ther. Adv. Drug Saf. 10 (2019) 1–7; https://doi.org/10.1177/2042098619868640Search in Google Scholar

11N. N. Dhalwani, R. Fahami and H. Sathanapally, Association between polypharmacy and falls in older adults: A longitudinal study from England, BMJ Open . (2017) Article ID e016358 (8 pages); https://doi.org/10.1136/bmjopen-2017-016358Search in Google Scholar

12Q. Xu, X. Ou and J. Li, The risk of falls among the aging population: A systematic review and meta-analysis, Front Public Health 10 (2022) Article ID 902599 (10 pages); https://doi.org/10.3389/fpubh.2022.902599Search in Google Scholar

13S. Deandrea, E. Lucenteforte and F. Bravi, Risk Factors for falls in community-dwelling older people, Epidemiology 21 (2010) 658–668; https://doi.org/10.1097/EDE.0b013e3181e89905Search in Google Scholar

14A. Zia, S. B. Kamaruzzaman and M. P. Tan, Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk, Postgrad. Med. 127 (2015) 330–337; https://doi.org/10.1080/00325481.2014.996112Search in Google Scholar

15National Institute for Health and Care Excellence (NICE), Falls in older people, 2015; http://pathways.nice.org.uk/pathways/falls-in-older-people; last access date October 28, 2022.Search in Google Scholar

16P. Zaninotto, Y. T. Huang and G. di Gessa, Polypharmacy is a risk factor for hospital admission due to a fall: Evidence from the English Longitudinal Study of Ageing, BMC Public Health 20 (2020) Article ID 1804 (7 pages); https://doi.org/10.1186/s12889-020-09920-xSearch in Google Scholar

17E. P. van Poelgeest, A. C. Pronk, D. Rhebergen and N. van der Velde, Depression, antidepressants and fall risk: therapeutic dilemmas – a clinical review, Eur. Geriatr. Med. 12 (2021) 585–596; https://doi.org/10.1007/s41999-021-00475-7Search in Google Scholar

18P. J. Barry, P. Gallagher and C. Ryan, Inappropriate prescribing in geriatric patients, Curr. Psychiatry Rep. 10 (2008) 37–43; https://doi.org/10.1007/s11920-008-0008-3Search in Google Scholar

19L. J. Seppala, N. van der Velde and T. Masud, EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on knowledge dissemination, management, and future research, Drugs Aging 36 (2019) 299–307; https://doi.org/10.1007/s40266-018-0622-7Search in Google Scholar

20L. A. Hart, E. A. Phelan and J. Y. Yi, Use of fall risk increasing drugs around a fall-related injury in older adults: A systematic review, J. Am. Geriatr. Soc. 68 (2020) 1334–1343; https://doi.org/10.1111/jgs.16369Search in Google Scholar

21S. S. Laing, I. F. Silver, S. York and E. A. Phelan, Fall prevention knowledge, attitude, and practices of community stakeholders and older adults, J. Aging Res. (2011) 1–9; https://doi.org/10.4061/2011/395357Search in Google Scholar

22L. J. Seppala, M. Petrovic, J. Ryg, G. Bahat, E. Topinkova, K. Szczerbinska, T. J. M. van der Cammen, S. Hartikainen, B. Ilhan, F. Landi, Y. Morrissey, A. Mair, M. Gutiérrez-Valencia, M. H. Emmelot-Vonk, M. Á. Caballero Mora, M. Denkinger, P. Crome, S. H. D. Jackson, A. Correa-Pérez, W. Knol, G. Soulis, A. Gudmundsson, G. Ziere, M. Wehling, D. O’Mahony, A. Cherubini and N. van der Velde, STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): A Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs, Age Ageing 50 (2021) 1189–1199; https://doi.org/10.1093/ageing/afaa249Search in Google Scholar

23S. B. Lee, J. H. Oh and J. H. Park, Differences in youngest-old, middle-old, and oldest-old patients who visit the emergency department, Clin. Exp. Emerg. Med. 5 (2018) 249–255; https://doi.org/10.15441/ceem.17.261Search in Google Scholar

24T. R. L. Machado, C. A. Menezes de Pádua and P. L. Drummond de M, Use of fall risk-increasing drugs in older adults with multiple myeloma, A cross-sectional study, J. Geriatr. Oncol. 13(4) (2022) 493–498; https://doi.org/10.1016/j.jgo.2022.01.007Search in Google Scholar

25N. Cox, I. Ilyas, H. C. Roberts and K. Ibrahim, Exploring the prevalence and types of fall-risk-increasing drugs among older people with upper limb fractures, Int. J. Pharm. Practice 31 (1) (2022) 106–112; https://doi.org/10.1093/ijpp/riac084Search in Google Scholar

26B. A. Damoiseaux-Volman, K. Raven and D. Sent, Potentially inappropriate medications and their effect on falls during hospital admission, Age Ageing 51 (2022) 1–8; https://doi.org/10.1093/ageing/afab205Search in Google Scholar

27C. U. Andersen, P. O. Lassen and H. Q. Usman, Prevalence of medication-related falls in 200 consecutive elderly patients with hip fractures: A cross-sectional study, BMC Geriatr. 20 (2020) Article ID 121 (7 pages); https://doi.org/10.1186/s12877-020-01532-9Search in Google Scholar

28G. Airagnes, A. Pelissolo and M. Lavallée, Benzodiazepine misuse in the elderly: Risk factors, consequences, and management, Curr. Psychiatry Rep. 18 (2016) Article ID 89 (9 pages); https://doi.org/10.1007/s11920-016-0727-9Search in Google Scholar

29L. A. Hart, E. A. Phelan and J. Y. Yi, Use of fall risk-increasing drugs around a fall-related injury in older adults: A systematic review, J. Am. Geriatr. Soc. 68(6) (2020) 1334–1343; https://doi.org/10.1111/jgs.16369Search in Google Scholar

30K. Heckenbach, T. Ostermann and F. Schad, Medication and falls in elderly outpatients: an epidemiological study from a German Pharmacovigilance Network, Springerplus . (2014) Article ID 483 (9 pages); https://doi.org/10.1186/2193-1801-3-483Search in Google Scholar

31K. Ie, E. Chou, R. D. Boyce and S. M. Albert, Fall risk-increasing drugs, polypharmacy, and falls among low-income community-dwelling older adults, Innov. Aging .(1) (2021) 1–9; https://doi.org/10.1093/geroni/igab001Search in Google Scholar

32B. J. Ng, D. G. le Couteur and S. N. Hilmer, Deprescribing benzodiazepines in older patients: Impact of interventions targeting physicians, pharmacists, and patients, Drugs Aging 35(6) (2018) 493–521; https://doi.org/10.1007/s40266-018-0544-4Search in Google Scholar

33J. Glass, K. L. Lanctôt and N. Herrmann, Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits, Br. Med. J. 331 (2005) Article ID 1169 (7 pages); https://doi.org/10.1136/bmj.38623.768588.47Search in Google Scholar

34G. Zhong, Y. Wang, Y. Zhang and Y. Zhao, Association between benzodiazepine use and dementia: A meta-analysis, PLoS One 10(5) (2015) e0127836 (16 pages); https://doi.org/10.1371/journal.pone.0127836Search in Google Scholar

35M. M. Islam, U. Iqbal and B. Walther, Benzodiazepine use and risk of dementia in the elderly population: A systematic review and meta-analysis, Neuroepidemiology 47(3–4) (2016) 181–191; https://doi.org/10.1159/000454881Search in Google Scholar

36M. Markota, T. A. Rummans, J. M. Bostwick and M. I. Lapid, Benzodiazepine use in older adults: Dangers, management, and alternative therapies, Mayo Clin. Proc. 91 (2016) 1632–1639; https://doi.org/10.1016/j.mayocp.2016.07.024Search in Google Scholar

37APA Work Group on Alzheimer’s Disease and other Dementias; P. V. Rabins, D. Blacker et al., Ameri can Psychiatric Association practice guideline for the treatment of patients with Alzheimer’s disease and other dementias, 2nd ed., Am. J. Psychiatry 164 (2007) 5–56.Search in Google Scholar

38O. J. Bogunovic and S. F. Greenfield, Practical geriatrics: Use of benzodiazepines among elderly patients, Psychiatric Services 55 (2004) 233–235; https://doi.org/10.1176/appi.ps.55.3.233Search in Google Scholar

39L. Burry, J. Turner and T. Morgenthaler, Addressing barriers to reducing prescribing and implementing derescribing of sedative-hypnotics in primary care, Ann. Pharmacotherapy 56(4) (2022) 463–474; https://doi.org/10.1177/10600280211033022Search in Google Scholar

40S. I. Haider, K. Johnell and G. R. Weitoft, The influence of educational level on polypharmacy and inappropriate drug use: A register-based study of more than 600,000 older people, J. Am. Geriatr. Soc. 57 (2009) 62–69; https://doi.org/10.1111/j.1532-5415.2008.02040.xSearch in Google Scholar

41D. Walckiers, J. van der Heyden and J. Tafforeau, Factors associated with excessive polypharmacy in older people, Arch. Pub. Health 73 (2015) Article ID 50 (12 pages); https://doi.org/10.1186/s13690-015-0095-7Search in Google Scholar

42J. Jyrkkä, H. Enlund and M. J. Korhonen, Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons, Drugs Aging 26 (2009) 493–503; https://doi.org/10.2165/00002512-200926060-00006Search in Google Scholar

43A. Rieckert, U. S. Trampisch and R. Klaaßen-Mielke, Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy, BMC Fam. Pract. 19 (2018) Article ID 113 (9 pages); https://doi.org/10.1186/s12875-018-0795-5Search in Google Scholar

44G. Onder, R. Liperoti and D. Fialova, Polypharmacy in nursing home in Europe: Results from the SHELTER study, J. Gerontol. A Biol. Sci. Med. Sci. 67A (2012) 698–704; https://doi.org/10.1093/gerona/glr233Search in Google Scholar

45H. A. Kim, J. Y. Shin M. H. Kim and B. J. Park, Prevalence and predictors of polypharmacy among Korean elderly, PLoS One . (2014) e98043 (7 pages); https://doi.org/10.1371/journal.pone.0098043Search in Google Scholar

46S. J. Lee, R. M. Leipzig and L. C. Walter, Incorporating lag time to benefit into prevention decisions for older adults, JAMA 310(24) (2013) 2609–2610; https://doi.org/10.1001/jama.2013.282612Search in Google Scholar

47D. Fialová, E. Topinková and G. Gambassi, Potentially inappropriate medication use among elderly home care patients in Europe, JAMA 293(11) (2005) 1348–1358; https://doi.org/10.1001/jama.293.11.1348Search in Google Scholar

48C. D. Black, K. Thavorn, D. Coyle and L. M. Bjerre, The health system costs of potentially inappropriate prescribing: A population-based, retrospective cohort study using linked health administrative databases in Ontario, Canada, Pharmacoecon. Open . (2020) 27–36; https://doi.org/10.1007/s41669-019-0143-2Search in Google Scholar

49S. Mucherino, M. Casula, F. Galimberti, I. Guarino, E. Olmastroni, E. Tragni, V. Orlando and E. Menditto, on behalf of the EDU.RE.DRUG Group, The effectiveness of interventions to evaluate and reduce healthcare costs of potentially inappropriate prescriptions among the older adults: A systematic review, Int. J. Environ. Res. Public Health 19 (2022) Article ID 6724 (19 pages); https://doi.org/10.3390/ijerph19116724Search in Google Scholar

50A. D. Meid, R. Quinzler, J. Freigofas, K. U. Saum, B. Schöttker, B. Holleczek, D. Heider, H. H. König, H. Brenner and W. E. Haefeli, Medication underuse in aging outpatients with cardiovascular disease: Prevalence, determinants, and outcomes in a prospective cohort study, PLoS One 10(8) (2015) e0136339 (12 pages); https://doi.org/10.1371/journal.pone.0136339Search in Google Scholar

51N. van der Velde, L. Seppala, M. Petrovic, J. Ryg, M. P. Tan, M. Montero-Odasso, F. C. Martin and T. Masud, Sustainable fall prevention across Europe: Challenges and opportunities, Aging Clin. Exp. Res. 34 (2022) 2553–2556; https://doi.org/10.1007/s40520-022-02178-wSearch in Google Scholar

52M. Gemmeke, E. S. Koster, O. Janatgol, K. Taxis and M. L. Bouvy, Pharmacy fall prevention services for the community-dwelling elderly: Patient engagement and expectations, Health Soc. Care Community 30 (2022) 1450–1461; https://doi.org/10.1111/hsc.13475Search in Google Scholar

53M. Gemmeke, E. S. Koster, E. A. Rodijk, K. Taxis and M. L. Bouvy, Community pharmacists’ perceptions on providing fall prevention services: A mixed-methods study, Int. J. Clin. Pharm. 43 (2021) 1533–1545; https://doi.org/10.1007/s11096-021-01277-4Search in Google Scholar

54N. Ailabouni, D. Mangin and P. S. Nishtala, DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities, Int. J. Clin. Pharm. 41 (2019) 167–178; https://doi.org/10.1007/s11096-019-00784-9Search in Google Scholar

55L. J. Seppala, N. Kamkar, E. P. van Poelgeest, K. Thomsen, J. G. Daams, J. Ryg, T. Masud, M. Montero-Odasso, S. Hartikainen, M. Petrovic, N. van der Velde and the Task Force on Global Guidelines for Falls in Older Adults, Medication reviews and deprescribing as a single intervention in falls prevention: a systematic review and meta-analysis, Age Ageing 51(9) (2022) Article ID afac91 (12 pages); https://doi.org/10.1093/ageing/afac191Search in Google Scholar

56R. A. Kalim, C. J. Cunningham, S. A. Ryder and N. M. McMahon, Deprescribing medications that increase the risk of falls in older people: Exploring doctors’ perspectives using the Theoretical Domains Framework (TDF), Drugs Aging 39 (2022) 935–947; https://doi.org/10.1007/s40266-022-00985-4Search in Google Scholar

57N. D. A. Boyé, N. van der Velde, O. J. de Vries, E. M. M. van Lieshout, K. A. Hartholt, F. U. S. Mattace-Raso, P. Lips, P. Patka, E. F. van Beeck, T. J. M. van der Cammen and IMPROveFALL trial collaborators, Effectiveness of medication withdrawal in older fallers: Results from the improving medication prescribing to reduce risk of falls (IMPROveFALL) trial, Age Ageing 46 (2017) 142–146; https://doi.org/10.1093/ageing/afw161Search in Google Scholar

58S. Polinder, N. D. A. Boyé, F. U. S. Mattace-Raso, N. Van der Velde, K. A. Hartholt, O. J. De Vries, P. Lips, T. J. M. Van der Cammen, P. Patka, E. F. Van Beeck, E. M. M. Van Lieshout and the IMPROve-FALL trial collaborators, Cost-utility of medication withdrawal in older fallers: Results from the improving medication prescribing to reduce risk of FALLs (IMPROveFALL) trial, BMC Geriatr. 16 (2016) Article ID 179 (10 pages); https://doi.org/10.1186/s12877-016-0354-7Search in Google Scholar

59J. Lee, A. Negm, R. Peters, E. K. C. Wong and A. Holbrook, Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis, BMJ Open 11(2) (2021) Article ID e035978 (10 pages); https://doi.org/10.1136/bmjopen-2019-035978Search in Google Scholar